Mebendazole as Adjuvant Treatment for Colon Cancer
ConditionColorectal Cancer
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorSherief Abd-Elsalam
About this trial
mebendazole treating colon cancer
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Colorectal cancer stage 4.
Disqualifiers
Agranulocytosis
Pregnancy
Allergy to mebendazole.
Trial design
Design model
Parallel
Treatments tested in this trial
Folfox with avastin
DrugFolfox with avastin only
Mebendazole
DrugFolfox with avastin with mebendazole
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Folfox with avastinActive comparator 1 intervention
Group B: MebendazoleExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
number of patients with tumour response
number of patients with response
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov